Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus

Abstract

A significant percentage of patients have moderately-to-severely active SLE at some stage. Disease activity has a big impact in terms of need for treatment and cause of hospitalization. The effectiveness of the standard therapies for reducing disease activity is clearly insufficient. Some clinical features are associated with refractory SLE.